The deal priced below last closing price of $2.96. Maxim is acting as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXL:
- Nexalin Technology Announces Pricing of $5.2 Million Public Offering
- Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
- Nexalin Technology announces ‘positive’ study data in MDD
- 3 Penny Stocks to Watch Now, 6/25/24
- Nexalin Technology awarded patent related to deep-brain stimulation device
